| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Cancer Research and Treatment Search > Browse Articles > Search



Breast cancer
β1,4-Galactosyltransferase V Modulates Breast Cancer Stem Cells through Wnt/β-catenin Signaling Pathway
Wei Tang, Meng Li, Xin Qi, Jing Li
Cancer Res Treat. 2020;52(4):1084-1102.   Published online May 27, 2020    DOI: https://doi.org/10.4143/crt.2020.093
                              Supplementary         Cited By 1
Real-World Data of Pyrotinib-Based Therapy in Metastatic HER2-Positive Breast Cancer: Promising Efficacy in Lapatinib-Treated Patients and in Brain Metastasis
Ying Lin, Mingxi Lin, Jian Zhang, Biyun Wang, Zhonghua Tao, Yiqun Du, Sheng Zhang, Jun Cao, Leiping Wang, Xichun Hu
Cancer Res Treat. 2020;52(4):1059-1066.   Published online April 24, 2020    DOI: https://doi.org/10.4143/crt.2019.633
                              Supplementary         Cited By 1
RON and MET Co-overexpression Are Significant Pathological Characteristics of Poor Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Triple-Negative Breast Cancer
Tian-Hao Weng, Min-Ya Yao, Xiang-Ming Xu, Chen-Yu Hu, Shu-Hao Yao, Yi-Zhi Liu, Zhi-Gang Wu, Tao-Ming Tang, Pei-Fen Fu, Ming-Hai Wang, Hang-Ping Yao
Cancer Res Treat. 2020;52(3):973-986.   Published online April 22, 2020    DOI: https://doi.org/10.4143/crt.2019.726
                              Supplementary         Cited By 3
Detection of Germline Mutations in Breast Cancer Patients with Clinical Features of Hereditary Cancer Syndrome Using a Multi-Gene Panel Test
Hee-Chul Shin, Han-Byoel Lee, Tae-Kyung Yoo, Eun-Shin Lee, Ryong Nam Kim, Boyoung Park, Kyong-Ah Yoon, Charny Park, Eun Sook Lee, Hyeong-Gon Moon, Dong-Young Noh, Sun-Young Kong, Wonshik Han
Cancer Res Treat. 2020;52(3):697-713.   Published online February 4, 2020    DOI: https://doi.org/10.4143/crt.2019.559
                              Supplementary         Cited By 4
PIK3CA H1047R Mutation Associated with a Lower Pathological Complete Response Rate in Triple-Negative Breast Cancer Patients Treated with Anthracycline-Taxane–Based Neoadjuvant Chemotherapy
Sanxing Guo, Sibylle Loibl, Gunter von Minckwitz, Silvia Darb-Esfahani, Bianca Lederer, Carsten Denkert
Cancer Res Treat. 2020;52(3):689-696.   Published online February 4, 2020    DOI: https://doi.org/10.4143/crt.2019.497
                                 Cited By 2
Prevalence of PALB2 Germline Mutations in Early-onset and Familial Breast/Ovarian Cancer Patients from Pakistan
Muhammad Usman Rashid, Faiz Ali Khan, Noor Muhammad, Asif Loya, Ute Hamann
Cancer Res Treat. 2019;51(3):992-1000.   Published online October 11, 2018    DOI: https://doi.org/10.4143/crt.2018.356
                                 Cited By 1
Different Patterns of Risk Reducing Decisions in Affected or Unaffected BRCA Pathogenic Variant Carriers
Eun-Gyeong Lee, Hyok Jo Kang, Myong Cheol Lim, Boyoung Park, Soo Jin Park, So-Youn Jung, Seeyoun Lee, Han-Sung Kang, Sang-Yoon Park, Boram Park, Jungnam Joo, Jai Hong Han, Sun-Young Kong, Eun Sook Lee
Cancer Res Treat. 2019;51(1):280-288.   Published online May 4, 2018    DOI: https://doi.org/10.4143/crt.2018.079
                                 Cited By 1
Psychosocial Health of Disease-Free Breast Cancer Survivors Compared with Matched Non-cancer Controls
Boyoung Park, Moo Hyun Lee, Sun-Young Kong, Eun Sook Lee
Cancer Res Treat. 2019;51(1):178-186.   Published online April 5, 2018    DOI: https://doi.org/10.4143/crt.2017.585
                                 Cited By 1
Randomized Open Label Phase III Trial of Irinotecan Plus Capecitabine versus Capecitabine Monotherapy in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01)
In Hae Park, Seock-Ah Im, Kyung Hae Jung, Joo Hyuk Sohn, Yeon Hee Park, Keun Seok Lee, Sung Hoon Sim, Kyong-Hwa Park, Jee Hyun Kim, Byung Ho Nam, Hee-Jun Kim, Tae-Yong Kim, Kyung-Hun Lee, Sung-Bae Kim, Jin-Hee Ahn, Suee Lee, Jungsil Ro
Cancer Res Treat. 2019;51(1):43-52.   Published online February 14, 2018    DOI: https://doi.org/10.4143/crt.2017.562
                                 Cited By 7
Safety Results and Analysis of Eribulin Efficacy according to Previous Microtubules-Inhibitors Sensitivity in the French Prospective Expanded Access Program for Heavily Pre-treated Metastatic Breast Cancer
Renaud Sabatier, Véronique Diéras, Xavier Pivot, Etienne Brain, Henri Roché, Jean-Marc Extra, Audrey Monneur, Magali Provansal, Carole Tarpin, François Bertucci, Patrice Viens, Christophe Zemmour, Anthony Gonçalves
Cancer Res Treat. 2018;50(4):1226-1237.   Published online December 28, 2017    DOI: https://doi.org/10.4143/crt.2017.446
                              Supplementary         Cited By 4
Evaluation of the Benefit of Radiotherapy in Patients with Occult Breast Cancer: A Population-Based Analysis of the SEER Database
Byoung Hyuck Kim, Jeanny Kwon, Kyubo Kim
Cancer Res Treat. 2018;50(2):551-561.   Published online June 1, 2017    DOI: https://doi.org/10.4143/crt.2017.189
                              Supplementary         Cited By 5
Clinically Significant Unclassified Variants in BRCA1 and BRCA2 Genes among Korean Breast Cancer Patients
Kyong-Ah Yoon, Boyoung Park, Byung Il Lee, Moon Jung Yang, Sun-Young Kong, Eun Sook Lee
Cancer Res Treat. 2017;49(3):627-634.   Published online September 13, 2016    DOI: https://doi.org/10.4143/crt.2016.292
                                 Cited By 8
An Open-Label, Randomized, Parallel, Phase III Trial Evaluating the Efficacy and Safety of Polymeric Micelle-Formulated Paclitaxel Compared to Conventional Cremophor EL-Based Paclitaxel for Recurrent or Metastatic HER2-Negative Breast Cancer
In Hae Park, Joo Hyuk Sohn, Sung Bae Kim, Keun Seok Lee, Joo Seop Chung, Soo Hyeon Lee, Tae You Kim, Kyung Hae Jung, Eun Kyung Cho, Yang Soo Kim, Hong Suk Song, Jae Hong Seo, Hun Mo Ryoo, Sun Ah Lee, So Young Yoon, Chul Soo Kim, Yong Tai Kim, Si Young Kim, Mi Ryung Jin, Jungsil Ro
Cancer Res Treat. 2017;49(3):569-577.   Published online September 12, 2016    DOI: https://doi.org/10.4143/crt.2016.289
                                 Cited By 31
Efficacy of Letrozole as First-Line Treatment of Postmenopausal Women with Hormone Receptor–Positive Metastatic Breast Cancer in Korea
Seung Hoon Beom, Jisu Oh, Tae-Yong Kim, Kyung-Hun Lee, Yaewon Yang, Koung Jin Suh, Hyeong-Gon Moon, Sae-Won Han, Do-Youn Oh, Wonshik Han, Tae-You Kim, Dong-Young Noh, Seock-Ah Im
Cancer Res Treat. 2017;49(2):454-463.   Published online August 23, 2016    DOI: https://doi.org/10.4143/crt.2016.259
                                 Cited By 1
Improving Conventional or Low Dose Metronomic Chemotherapy with Targeted Antiangiogenic Drugs
Robert S. Kerbel
Cancer Res Treat. 2007;39(4):150-159.   Published online December 31, 2007    DOI: https://doi.org/10.4143/crt.2007.39.4.150
                                 Cited By 32
A Locally Advanced Breast Cancer with Difficult Differential Diagnosis of Carcinosarcoma and Atypical Medullary Carcinoma, which had Poor Response to Adriamycin- and Taxane-based Neoadjuvant Chemotherapy: A Case Report
Se Hyun Kim, Hyun Cheol Chung, Jaeheon Jeong, Ji Hoon Kim, Sun Young Rha, Joong Bae Ahn, Nam Hoon Cho, Hei-Cheul Jeung
Cancer Res Treat. 2007;39(3):134-137.   Published online September 30, 2007    DOI: https://doi.org/10.4143/crt.2007.39.3.134
                                 Cited By 1
Effects of the Expression of Leptin and Leptin Receptor (OBR) on the Prognosis of Early-stage Breast Cancers
Yongnam Kim, Si-Young Kim, Jae Jin Lee, Jeongho Seo, Youn-Wha Kim, Suck Hwan Koh, Hwi-Joong Yoon, Kyung Sam Cho
Cancer Res Treat. 2006;38(3):126-132.   Published online June 30, 2006    DOI: https://doi.org/10.4143/crt.2006.38.3.126
                                 Cited By 10
Serum HER2 as a Response Indicator to Various Chemotherapeutic Agents in Tissue HER2 Positive Metastatic Breast Cancer
Sun-Young Kong, Do Hoon Lee, Eun Sook Lee, Susan Park, Keun Seok Lee, Jungsil Ro
Cancer Res Treat. 2006;38(1):35-39.   Published online February 28, 2006    DOI: https://doi.org/10.4143/crt.2006.38.1.35
                                 Cited By 11
Expression of Cyclooxygenase-2 in Human Breast Cancer: Relationship with HER-2/neu and other Clinicopathological Prognostic Factors
Eunmi Nam, Soon Nam Lee, Seock-Ah Im, Do-Yeun Kim, Kyoung Eun Lee, Sun Hee Sung
Cancer Res Treat. 2005;37(3):165-170.   Published online June 30, 2005    DOI: https://doi.org/10.4143/crt.2005.37.3.165
                                 Cited By 5
The Differential Gene Expression Profiles between Sensitive and Resistant Breast Cancer Cells to Adriamycin by cDNA Microarray
Myung-Ju Ahn, Ki-Hwan Lee, Joon-Ik Ahn, Dong-Hyun Yu, Hye-Sook Lee, Jung-Hye Choi, Joung Soon Jang, Jong Min Bae, Yong-Sung Lee
Cancer Res Treat. 2004;36(1):43-49.   Published online February 29, 2004    DOI: https://doi.org/10.4143/crt.2004.36.1.43
                                 Cited By 7
Korean Breast Cancer Data of 1997
J Korean Cancer Assoc. 1999;31(6):1202-1209.
      
Prognostic Significance of Occult Lymph Node Metastases in Breast Cancer
Won Cheol Park, Kyoung Keun Lee, Kwong Man Lee, Ki Jung Yun
J Korean Cancer Assoc. 1999;31(6):1195-1201.
      
The Predictors of Axillary Node Metastasis in 2 cm or Less Breast Cancer
Han Sung Kang, Dong Young Noh, Oh Joong Kwon, Yeo Kyu Youn, Seung Keun Oh, Kuk Jin Choe
J Korean Cancer Assoc. 1999;31(6):1188-1194.
      
Effect of Adjuvant Chemotherapy of Operable Breast Cancer : Survival and Prognostic Factor Analysis
Jeong Gyun Kim, Tae Won Kim, Je Hwan Lee, Sung Bae Kim, Cheolwon Suh, Kyoo Hyung Lee, Jung Shin Lee, Sei Hyun Ahn, Hyesook Chang, Sang Hee Kim, Woo Kun Kim
J Korean Cancer Assoc. 1999;31(5):1018-1026.
      
Study on the Apoptosis in Human Prostate and Breast Cancer Cells
Eun Jeong Kwon, Myung Sun Lee
J Korean Cancer Assoc. 1999;31(4):728-738.
      
Sequencing of p53 Gene Mutations in Primary Breast Cancer Tissues
Jeoung Won Bae, Bum Hwan Koo, Cheung Wung Whang, Seul Hee Park, In Sun Kim
J Korean Cancer Assoc. 1999;31(4):663-669.
      
Correlation of Breast Cancer with Atypical Ductal Hyperplasia on Fine-needle Aspiration Cytology Speciemens
Lee Su Kim, Jin Hee Sohn, Jeong Jin Kim, Jong Hyun Kim, Kyung Ho Cha, Song Kim, Chang Sig Choi, Bong Hwa Lee
J Korean Cancer Assoc. 1999;31(3):517-522.
      
Patterns of the Recurrence of Breast Cancer in Korean Female Patients
Hark Kyun Kim, Dae Seog Heo, Yung Jue Bang, Noe Kyeong Kim
J Korean Cancer Assoc. 1999;31(3):509-516.
      
Breast Cancer Detected by Screening Mammography
Byung Ho Son, Jung Mi Park, Gyeong Yeop Gong, Se Hyun Ahn
J Korean Cancer Assoc. 1999;31(3):499-508.
      
Reduced Expression of p27 Correlates with High Grade Malignancy and is Associated with Poor Clinical Outcome in Human Greast Cancer
Se Hwan Han, Hong Yong Kim, Kyeong Mee Park, Myeong Soo Lee, Hong Joo Kim, Young Doug Kim, Hyun Suk Suh
J Korean Cancer Assoc. 1999;31(3):492-498.
      
Korean Cancer Association
E-Submission
EndNote Output Style
Email Alert
Impact factor
SCImago Journal & Country Rank
PubMed Central
MEDLINE/PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
ORCID
COPE
Editorial Office
Korean Cancer Association
Room 1824, Gwanghwamun Officia
92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
TEL: +82-2-3276-2410   FAX: +82-2-792-1410   E-mail: journal@cancer.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © Korean Cancer Association. All rights reserved.                 Developed in M2PI